Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CASP2 | P42575 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 2/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.38 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.35 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL8508947 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL1258383 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL43361 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL160900 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL1389613 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL2762938 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL3912001 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL7142445 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL21641467 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 | |
| Pyridine SCHEMBL11233102 | 1.00 | TSHR (0.59) | TSHRALDH1A1TDP1NAPRTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110113942-A | Synergistic antimicrobial compositions | 朱比兰特生命科学有限公司 | 2019-08-09 | — | — | CN | claimed |
| CN-103992426-B | A kind of antibacterial high water-absorbent resin and preparation method thereof | 浙江卫星石化股份有限公司 | 2017-03-29 | — | — | CN | claimed |
| CN-105744836-A | ANTI-DANDRUFF COMPOSITIONS AND HAIR CARE FORMULATIONS CONTAINING ZINC PYRITHIONE AND QUATERNARY AMMONIUM SALT | 吉友联生命科学有限公司 | 2016-07-06 | — | — | CN | claimed |
| CN-104818002-A | Filtrate reducer for palm oil, and preparation method thereof | UNIV CHINA PETROLEUM | 2015-08-05 | — | — | CN | claimed |
| WO-2001051767-A2 | ADDITION OF SOLIDS TO GENERATE VISCOSITY DOWNHOLE | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2001-07-19 | — | — | WO | claimed |
| EP-0600659-B1 | Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives | XEROX CORP (US) | 1997-07-30 | — | — | EP | claimed |
| EP-0600659-A1 | Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives | XEROX CORPORATION (US) | 1994-06-08 | — | — | EP | claimed |
| US-5304449-A | Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives | XEROX CORPORATION (US) | 1994-04-19 | — | — | US | claimed |
| EP-0278846-B1 | COSMETIC COMPOSITION IN SPRAY OR AEROSOL FORM FOR THE CARE, TREATMENT AND AESTHETICS OF THE HAIR | LABORATOIRE LACHARTRE SOCIETE ANONYME: (FR) | 1992-04-15 | — | — | EP | claimed |
| EP-0004953-B1 | PROCESS AND APPARATUS FOR THE SELECTIVE SEPARATION OF URANIUM FROM ITS ACCOMPANYING METALS AND FOR ITS RECOVERY | Heckmann, Klaus, Prof. Dr. (DE) | 1982-03-03 | — | — | EP | claimed |
| US-20260042956-A1 | METHOD FOR SINGLE-STAGE TREATMENT OF SILICEOUS SUBTERRANEAN FORMATIONS | SCHLUMBERGER TECHNOLOGY CORPORATION | 2026-02-12 | — | — | US | disclosed |
| CN-110880552-B | Perovskite solution and surfactant step-by-step coating equipment and method thereof | 杭州纤纳光电科技有限公司 | 2024-10-18 | — | — | CN | disclosed |
| WO-2024141403-A1 | ANHYDROUS CLEANSING COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141375-A1 | TRANSLUCENT OR TRANSPARENT ISOTROPIC LIQUID WASH COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141377-A1 | ISOTROPIC LIQUID WASH COMPOSITION WITH ESTERIFIED NONIONIC THICKENER | UNILEVER IP HOLDINGS B.V. (NL) | 2024-07-04 | — | — | WO | disclosed |
| US-4264697-A | TONER RESIN, COLORANT, AND A CHARGE INDUCTING HYDRAZINIUM OR PYRIDINIUM COMPOUND | XEROX CORPORATION (US) | 1981-04-28 | — | — | US | disclosed |
| EP-0022347-A1 | Electrostatographic developer mixture | XEROX CORPORATION (US) | 1981-01-14 | — | — | EP | disclosed |
| EP-0005952-A1 | Electrostatographic toner containing an alkyl pyridinium compound and imaging method | XEROX CORPORATION (US) | 1979-12-12 | — | — | EP | disclosed |
| US-4156887-A | PYRIDINE, QUINOLINE OR 1,10-PHENANTHROLINE COMPOUND HAVING REVERSIBLE PHASE TRANSITION | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1979-05-29 | — | — | US | disclosed |
| US-4041205-A | SURFACTANTS AND A REINFORCEMENT SELECTED FROM CELLULOSE, PROTEIN, AND NYLON | COLGATE-PALMOLIVE COMPANY (US) | 1977-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042956-A1 | METHOD FOR SINGLE-STAGE TREATMENT OF SILICEOUS SUBTERRANEAN FORMATIONS | YAP1, S100A10, FOXM1 | TSHR 2378/4885ALDH1A1 4656/4885TDP1 3039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.